Status:
COMPLETED
A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Collaborating Sponsors:
Formulario MAgistral Farmacias Ahumada
Conditions:
Primary Sjogren
Secondary Sjogren
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess and compare the safetyness and efficacy of pilocarpine drops versus artificial saliva as symptomatic treatment for dry mouth and dry eyes caused by SS in a multi...
Detailed Description
Title: Xerostomy treatment in patients with Sjogren's syndrome in Chile :A double blind control trial comparing orally Pilocarpine drops and Artificial Saliva Authors: Cristian Vera Kellet, Mirtha ...
Eligibility Criteria
Inclusion
- Patiens over 18 years, with primary or secondary Sjogren's Syndrome and xerostomia.
Exclusion
- Patiens with cardiac, pulmonary, renal, gastric diseases,
- Patients with diabetes, glaucoma, Multipleesclerosis,
- Pregnant women.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00438048
Start Date
November 1 2006
End Date
May 1 2008
Last Update
May 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad Docente Asociada Dermatologia. Escuela de MEdicina Pontificia Universidad Catolica de Chile
Santiago, Santiago Metropolitan, Chile